Offerings / Regulation CF / Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed April 28, 2026 · San Diego, California
Repeat issuerPreferredRevenue over $1MCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on December 1, 2015, based in San Diego, CA, with 2 employees and $2,535,657 of revenue in its most recent fiscal year.
Offering terms
- Security
- Preferred Stock
- Maximum
- $500,000.00
- Price
- $0.91 per unit
- Pricing method
- Dividing pre-money valuation $59,400,000.00 (or $54,000,000.00 for investors in the first $249,999.32) by number of shares outstanding on fully diluted basis taking into account converting convertible securities and an option pool top off.
- Deadline
- April 30, 2027
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- 6.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
- Intermediary equity
- No
- Co-issuer
- Rejuvenate Bio I, a series of Wefunder SPV, LLC
Rejuvenate Bio I EB, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $2,535,657 | $0 |
| Cost of goods sold | $2,257,925 | $218,824 |
| Net income (loss) | -$1,837,486 | -$2,930,382 |
| Total assets | $1,988,496 | $2,134,379 |
| Cash and equivalents | $2,954 | $70,701 |
| Accounts receivable | $288,547 | $335,348 |
| Short-term debt | $8,985,924 | $8,094,966 |
| Long-term debt | $4,487,734 | $5,383,366 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 2 employees. Offered in 56 states.